Correction: Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma.

Correction: Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma.

Bibliographic Details
Main Author:	PLOS ONE Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4686124?pdf=render

Similar Items

Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma.
by: Yinghao Shen, et al.
Published: (2015-01-01)

Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma
by: Mona M Zoheiry, et al.
Published: (2015-12-01)

Molecular Serum Markers of Liver Fibrosis
by: Tianhui Liu, et al.
Published: (2012-01-01)

Retraction: Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria.
by: PLOS ONE Editors
Published: (2019-01-01)

Correction: Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma.
by: PLOS ONE Staff
Published: (2018-01-01)

Correction: Alginate microencapsulated hepatocytes optimised for transplantation in acute liver failure.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation.
by: PLOS ONE Staff
Published: (2016-01-01)

Macrophages and platelets in liver fibrosis and hepatocellular carcinoma
by: Martina Casari, et al.
Published: (2023-12-01)

Correction: Antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts.
by: PLOS ONE Staff
Published: (2015-01-01)

Retraction: Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection.
by: PLOS ONE Editors
Published: (2019-01-01)

Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.
by: PLOS ONE Staff
Published: (2020-01-01)

Correction: Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.
by: Marcin Krawczyk, et al.
Published: (2017-01-01)

Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2019-01-01)

Correction: Pharmacokinetic characteristics, pharmacodynamic effect and in vivo antiviral efficacy of liver-targeted interferon alpha.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Adeno-associated viral vector serotype 5 poorly transduces liver in rat models.
by: PLOS ONE Staff
Published: (2015-01-01)

Surveillance for hepatocellular carcinoma in patients with advanced liver fibrosis
by: Angelo Sangiovanni, et al.
Published: (2021-01-01)

Correction: Prediction of all-cause mortality after liver transplantation using left ventricular systolic and diastolic function assessment.
by: PLOS ONE Staff
Published: (2019-01-01)

Correction: the relative biological effectiveness for carbon and oxygen ion beams using the raster-scanning technique in hepatocellular carcinoma cell lines.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Multipotent mesenchymal stem cells in lung fibrosis.
by: PLOS ONE Staff
Published: (2018-01-01)

Schistosomal liver fibrosis and hepatocellular carcinoma – case series of patients submitted to liver transplantation
by: Norma Arteiro Filgueira, et al.
Published: (2018-07-01)

Schistosomal liver fibrosis and hepatocellular carcinoma - case series of patients submitted to liver transplantation
by: Norma Arteiro Filgueira, et al.

Retraction: Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Correction: Identification and Expression Profiling of MicroRNAs in the Brain, Liver and Gonads of Marine Medaka (Oryzias melastigma) and in Response to Hypoxia.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Application and evaluation of interactive 3D PDF for presenting and sharing planning results for liver surgery in clinical routine.
by: PLOS ONE Staff
Published: (2015-01-01)

Impact of Liver Fibrosis Severity on Oncological Prognosis in Hepatocellular Carcinoma
by: Koya Yasukawa, et al.
Published: (2023-10-01)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
by: Qingling Chen, et al.
Published: (2023-09-01)

Non-invasive of liver fibrosis diagnostics: the role of serum markers
by: A. F. Sheptulina, et al.
Published: (2024-03-01)

Diagnostic value of serum markers of fibrosis in chronic liver diseases
by: E V Vinnitskaia, et al.
Published: (2013-02-01)

Correction: Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
by: PLOS ONE Staff
Published: (2021-01-01)

Retraction: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Correction: Serum Reactive Oxygen Metabolite Levels Predict Severe Exacerbations of Asthma.
by: PLOS ONE Staff
Published: (2016-01-01)

Correction: serum reference values for leptin in healthy infants.
by: PLOS ONE Staff
Published: (2015-01-01)

Retraction: Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2019-01-01)

Correction: identification of modulators of the nuclear receptor peroxisome proliferator-activated receptor α (PPARα) in a mouse liver gene expression compendium.
by: PLOS ONE Staff
Published: (2015-01-01)

Prognostic value of serum autotaxin in liver cirrhosis and prediction of hepatocellular carcinoma
by: Nagwa Ramadan Ahmed, et al.
Published: (2019-01-01)

Correction: Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
by: PLOS ONE staff
Published: (2020-01-01)

Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.
by: Marcin Krawczyk, et al.
Published: (2017-01-01)

Diagnostic Value of Serum Markers of Liver Fibrosis in Patients with HCV-Infection
by: S.L. Melanich
Published: (2013-11-01)